Overview
Pulmonary hypertension is a haemodynamic disorder defined by abnormally elevated blood pressure within the pulmonary arterial circulation, which increases right ventricular afterload and, if sustained, leads to right heart strain and failure. It arises through diverse mechanisms including remodelling and narrowing of the pulmonary arterioles, chronic hypoxaemia, left heart disease, thromboembolic obstruction, and systemic conditions that affect the pulmonary vasculature. Clinically it manifests as progressive dyspnoea, reduced exercise tolerance, and signs of right ventricular dysfunction, and its assessment relies on echocardiographic estimation of tricuspid regurgitant velocity alongside confirmatory testing. The condition frequently coexists with other cardiopulmonary and haematological disorders, which complicates diagnosis and management. Research gathered here reflects these intersections, examining pulmonary hypertension in an elderly HIV-infected population, the predictors of elevated tricuspid regurgitant velocity in sickle cell anaemia, comorbidities across chronic obstructive pulmonary disease phenotypes, and the broader spectrum of heart failure and congenital cardiac and diaphragmatic anomalies that influence pulmonary pressures. Additional contributions address microRNAs as diagnostic and therapeutic tools in hypertension and cardiorenal signalling pathways in heart failure. Collectively these peer-reviewed studies span the cardiovascular, respiratory, and systemic contexts in which pulmonary hypertension develops and is evaluated.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes
Clinical and Laboratory Predictors of Elevated TRV In Sickle Cell Anaemia
Heart Failure in Family Medicine
MicroRNAs: As A Novel Potential Tool for Diagnosis, Prognosis, and Therapeutic Agents in Hypertension.
Cardiorenal Signaling Pathways in Heart Failure: Good and Bad News
Factors Impacting Nutritional Status in Infants with Single Ventricle Physiology
Prenatal Prognostication of Congenital Diaphragmatic Hernia: What are we Looking at?
The Evolution of Fetal Surgery
Significance of Radiological Findings in Patients with Respiratory and Abdominal Manifestations of Covid-19
The Initial Result Of The First Living Donor Lung Transplantation Case In Vietnam
Prevalence of Congenital Heart Defects among Neonates in Port Harcourt, Rivers State, Nigeria
How this research is being cited
The 12 articles above have been cited 17 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · International Journal of Medicine and Health Development
-
2026 · International Journal of Cardiology Congenital Heart Disease
-
2026 · Immunity, Inflammation and Disease
-
2025 · Cureus
-
2025 · Cureus
-
Mobin Ghazaiean et al. · 2025 · PLoS ONE
-
2025 · PLoS ONE
-
2024 · Journal of the American Heart Association
A sample of recent works citing this journal's research on Pulmonary Hypertension, linking to each citing work.